Kara Cannon
2024
In 2024, Kara Cannon earned a total compensation of $999.4K as Chief Executive Officer at Enzo Biochem, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $78,000 |
| Salary | $376,423 |
| Stock Awards | $207,000 |
| Other | $37,929 |
| Total | $999,352 |
Cannon received $376.4K in salary, accounting for 38% of the total pay in 2024.
Cannon also received $300K in non-equity incentive plan, $78K in option awards, $207K in stock awards and $37.9K in other compensation.
Rankings
In 2024, Kara Cannon's compensation ranked 58th out of 185 executives tracked by ExecPay. In other words, Cannon earned more than 68.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 58 out of 185 | 69th |
Division Services | 21 out of 43 | 51st |
Major group Health Services | 4 out of 11 | 64th |
Industry group Medical And Dental Laboratories | 1 out of 8 | 88th |
Industry Medical Laboratories | 1 out of 8 | 88th |
Source: SEC filing on November 27, 2024.
Cannon's colleagues
We found two more compensation records of executives working with Kara Cannon at Enzo Biochem in 2024.